Newcastle-upon-Tyne Hospitals NHS Trust

newcastle-hospitals.nhs.uk

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

67

Active

6

Phase 3

4

Total enrollment

113,360

Pipeline matrix

Showing 2 of 2 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Risdiplam1
Nusinersen Injectable Product1

Next readouts

  • 2027-04-30

Top conditions

  • Rheumatoid Arthritis3
  • Mitochondrial Diseases2
  • Type 2 Diabetes Mellitus2
  • Acute Coronary Syndrome2
  • Healthy2
  • Parkinson's Disease2
  • Graves' Disease1
  • Obesity1

Frequently asked questions about Newcastle-upon-Tyne Hospitals NHS Trust

How many clinical trials does Newcastle-upon-Tyne Hospitals NHS Trust have on ClinicalTrials.gov?
Newcastle-upon-Tyne Hospitals NHS Trust is listed as the lead sponsor on 67 clinical trials in ClinicalTrials.gov, 6 of which are currently active (recruiting, enrolling, or ongoing).
How many of Newcastle-upon-Tyne Hospitals NHS Trust's trials are in Phase 3?
4 of Newcastle-upon-Tyne Hospitals NHS Trust's trials are in Phase 3, spread across 2 active drug programs.
What therapeutic areas does Newcastle-upon-Tyne Hospitals NHS Trust focus on?
Newcastle-upon-Tyne Hospitals NHS Trust's most-studied conditions on ClinicalTrials.gov are Rheumatoid Arthritis, Mitochondrial Diseases, Type 2 Diabetes Mellitus, Acute Coronary Syndrome, Healthy.
When are Newcastle-upon-Tyne Hospitals NHS Trust's next clinical trial readouts?
Newcastle-upon-Tyne Hospitals NHS Trust has 1 upcoming primary-completion readout tracked here; the soonest is “Adult SMA Research and Clinical Hub”, expected around 2027-04-30.